Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the liver disease diagnostics market size evolved in recent years?

The market size of liver disease diagnostics has witnessed a significant expansion in the last few years. It is projected to increase from $36.26 billion in 2024 to a remarkable $39.05 billion in 2025, representing a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this historic growth include the increasing number of acute and chronic liver disease cases, a rise in liver diseases, escalating alcohol consumption, heightened awareness about liver health, and the growth of the healthcare infrastructure.

What are the predictions for the liver disease diagnostics market size in the coming years?

Over the coming years, the market size of liver disease diagnostics is anticipated to witness robust growth. With a compound annual growth rate (CAGR) of 7.4%, it is projected to reach $52.04 billion by 2029. Factors like the surge in the geriatric population, increased funds in research and development, greater number of biopsy procedures and diseases, and heightened telemedicine usage contribute to this growth for the forecasted period. Core trends during this period are expected to be the advent of personalized medicine, technological progression in the creation of diagnostic kits and rapid tests, as well as technological innovation in the healthcare industry and diagnostic procedures.

Get your liver disease diagnostics market report here!

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

What key factors are fueling the growth of the liver disease diagnostics market?

The upward trend in alcohol intake is anticipated to boost the liver disease diagnostics market’s expansion in the future. The rise in alcohol intake can be attributed to changes in societal norms, better affordability, widespread accessibility, as well as escalating stress or mental health issues. Diagnostics for liver disease play a critical role in assessing the implications of alcohol intake on liver health, facilitating the early detection of signs of liver damage such as fatty liver, hepatitis or cirrhosis. For example, December 2022 statistics from the National Health Service, a governmental agency in England, indicated an age-related increase in the percentage of individuals who consumed alcohol in the previous 12 months, beginning at 62% for those between 16 to 24 years and spiking to 85% for individuals aged between 55 to 74 years. Hence, the rising consumption of alcohol is fueling the growth of the liver disease diagnostics market.

How is the global liver disease diagnostics market divided into key segments?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Genetic Testing, Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Endoscopy: Esophagogastroduodenoscopy (EGD), Capsule Endoscopy

4) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

5) By Other Diagnosis Techniques: Molecular Imaging, Biomarker Testing, Fibrosis Scoring Systems

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Who are the key firms paving the way for growth in the liver disease diagnostics market?

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMérieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, Aiforia Technologies Plc

Which trends are expected to transform the liver disease diagnostics market?

Major companies operating in the liver disease diagnostics market are focusing on developing innovative solutions, such as non-invasive tools for liver assessment, to develop more accurate and efficient diagnostic methods. A non-invasive tool for liver assessment refers to diagnostic methods that evaluate liver conditions using techniques like elastography or blood tests, avoiding the need for invasive procedures like biopsies. For instance, in September 2024, City Imaging & Clinical, an India-based diagnostic center, launched FibroScan, a non-invasive diagnostic tool for liver assessment, aimed at early detection of liver diseases such as non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This advanced technology allows for rapid and accurate measurements of liver stiffness and fat content without the need for invasive procedures like biopsies. The procedure is quick, typically lasting 5 to 15 minutes, involving the placement of a probe on the skin over the liver. The probe emits sound waves, which measure liver tissue stiffness, helping assess fibrosis or scarring.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20862

What regions are contributing significantly to the growth of the liver disease diagnostics market?

North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Liver Diseases Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Cancer Diagnostics Global Market Report 2025

https://thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Human Liver Model Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/human-liver-model-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: